Cited by 2,353HIV Research and TreatmentHIV/AIDS drug development and treatmentInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Open access

Heaton, R.K., Clifford, D.B., Franklin, D.R., Woods, S.P., Ake, C., Vaida, F., Ellis, R.J., Letendre, S.L., Marcotte, T.D., Atkinson, J.H., Rivera-Mindt, M., Vigil, O.R., Taylor, M.J., Collier, A.C., Marra, C.M., Gelman, B.B., McArthur, J.C., Morgello, S., Simpson, D.M., McCutchan, J.A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T.L., Wong, J., Grant, I., For the CHARTER Group·2010·Neurology

DOI 10.1212/wnl.0b013e318200d727PMC PMC2995535

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era of combination antiretroviral therapy (CART). METHODS: A total of 1,555 HIV-infected adults were recruited from 6 university clinics across the United States, with minimal exclusions. We used standardized neuromedical, psychiatric, and neuropsychological (NP) examinations, and recently published criteria for diagnosing HAND and classifying 3 levels of comorbidity (minimal to severe non-HIV risks for NP impairment). RESULTS: Fifty-two percent of the total sample had NP impairment, with higher rates in groups with greater comorbidity burden (40%, 59%, and 83%). Prevalence estimates for specific HAND diagnoses (excluding severely confounded cases) were 33% for asymptomatic neurocognitive impairment, 12% for mild neurocognitive disorder, and only 2% for HIV-associated dementia (HAD). Among participants with minimal comorbidities (n = 843), history of low nadir CD4 was a strong predictor of impairment, and the lowest impairment rate on CART occurred in the subset with suppressed plasma viral loads and nadir CD4 ≥200 cells/mm(3) (30% vs 47% in remaining subgroups). CONCLUSIONS: The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities. Future studies should clarify whether early disease events (e.g., profound CD4 decline) may trigger chronic CNS changes, and whether early CART prevents or reverses these changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318200d727

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Beck Depression Inventory–II
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Self-citation
Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
Letendre, S. L. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 831
Self-citation
The impact of HIV-associated neuropsychological impairment on everyday functioning
Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J. R., Moore, D. J., Bentley, H. A., McCutchan, J. A., REICKS, C., Grant, I., & THE HNRC GROUP (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704102130 · Cited by 726
Self-citation
The HNRC 500-Neuropsychology of Hiv infection at different disease stages
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700000230 · Cited by 636
Self-citation
HIV and antiretroviral therapy in the brain: neuronal injury and repair
Ellis, R. J., Langford, D., & Masliah, E. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn2040 · Cited by 533
Self-citation
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
Cartier, L., Hartley, O., Dubois‐Dauphin, M., & Krause, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 520
Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment
Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M. F., Comandini, U. V., Vlassi, C., Giulianelli, M., Galgani, S., Antinori, A., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318042e1ee · Cited by 323
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A. E., Heaton, R. K., Wallace, M. R., ABRAMSON, I. S., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410420503 · Cited by 318
Self-citation
Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV
Woods, S. P., Rippeth, J. D., Frol, A. B., Levy, J. K., Ryan, E., Soukup, V. M., Hinkin, C. H., Lazzaretto, D., Cherner, M., Marcotte, T. D., et al. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490509565 · Cited by 311
Self-citation

Show all 33 references

Sorted by citations

Items 401–500 of 1,002

Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-Infected Patients After Long-Term Treatment With Combination Antiretroviral Therapy
Pedersen, K. K., Pedersen, M., Gaardbo, J. C., Ronit, A., Hartling, H. J., Brüünsgaard, H., Gerstoft, J., Ullum, H., & Nielsen, S. D. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318289bced · Cited by 46
Evidence-informed recommendations for rehabilitation with older adults living with HIV: a knowledge synthesis
O’Brien, K. K., Solomon, P. E., Trentham, B., MacLachlan, D., MacDermid, J. C., Tynan, A., Baxter, L. N., Casey, A., Chegwidden, W., Robinson, G., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004692 · Cited by 46
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people
Clifford, D. B., Vaida, F., Kao, Y.-T., Franklin, D. R., Letendre, S. L., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001156 · Cited by 46
Self-citation
Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants
Ghosh, A. K., Rao, K. V., Nyalapatla, P. R., Kovela, S., Brindisi, M., Osswald, H. L., Reddy, B. S., Agniswamy, J., Wang, Y., Aoki, M., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201700824 · Cited by 46
Structural and functional brain imaging in acute HIV
Samboju, V., Philippi, C. L., Chan, P., Cobigo, Y., Fletcher, J. L. K., Robb, M. L., Hellmuth, J. M., Benjapornpong, K., Dumrongpisutikul, N., Pothisri, M., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.07.024 · Cited by 46
High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study
Animut, M. D., Sorrie, M. B., Workineh, Y., & Yihune, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0204636 · Cited by 46
Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis
Davis, A., Nightingale, S., Springer, P. E., Solomons, R., Arenivas, A., Wilkinson, R. J., Anderson, S. T. B., & Chow, F. C. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15516.1 · Cited by 46
HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1α, JNK and AP-1 pathway
Shah, A. B., Vaidya, N. K., Bhat, H. K., & Kumar, A. (2016) · Scientific Reports · doi:10.1038/srep18929 · Cited by 48
Host Genetic Factors Predisposing to HIV-Associated Neurocognitive Disorder
Kallianpur, A. R., & Levine, A. J. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0222-z · Cited by 45
Health-Related Quality of Life ‘Well-Being' in HIV Distal Neuropathic Pain is More Strongly Associated with Depression Severity than with Pain Intensity
Keltner, J. R., Vaida, F., Ellis, R. J., Moeller‐Bertram, T., Sanders, C., Duarte, N. A., Robinson‐Papp, J., Dworkin, R. H., Clifford, D. B., McArthur, J. C., et al. (2012) · Psychosomatics · doi:10.1016/j.psym.2012.05.002 · Cited by 45
Self-citation
Neurocognitive impairment in HIV-infected individuals with previous syphilis
Marra, C. M., Deutsch, R., Collier, A. C., Morgello, S., Letendre, S. L., Clifford, D. B., Gelman, B. B., McArthur, J. C., McCutchan, J. A., Simpson, D. M., et al. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462412472827 · Cited by 45
Self-citation
Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection
Price, R. W., Peterson, J. J., Fuchs, D., Angel, T. E., Zetterberg, H., Hagberg, L., Spudich, S., Smith, R. D., Jacobs, J., Brown, J. N., et al. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9491-3 · Cited by 45
Advancing research and practice in HIV and rehabilitation: a framework of research priorities in HIV, disability and rehabilitation
O’Brien, K. K., Ibáñez-Carrasco, F., Solomon, P. E., Harding, R., Cattaneo, J., Chegwidden, W., Gahagan, J., Baxter, L. N., Worthington, C., Gayle, P., et al. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0724-8 · Cited by 46
A SMARTPHONE APP TO SCREEN FOR HIV-RELATED NEUROCOGNITIVE IMPAIRMENT
Robbins, R. N., Brown, H., Ehlers, A., Joska, J. A., Thomas, K. G. F., Burgess, R., Byrd, D., & Morgello, S. (2014) · Journal of Mobile Technology in Medicine · doi:10.7309/jmtm.3.1.5 · Cited by 45
Self-citation
Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy
Janssen, M. A. M., Meulenbroek, O., Steens, S. C. A., Goraj, B. M., Bosch, M., Koopmans, P. P., & Kessels, R. P. C. (2015) · AIDS · doi:10.1097/qad.0000000000000824 · Cited by 45
Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women’s Interagency HIV Study
Vance, D. E., Rubin, L. H., Valcour, V., Waldrop‐Valverde, D., & Maki, P. M. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0340-x · Cited by 45
Substance P–mediated chemokine production promotes monocyte migration
Spitsin, S. V., Meshki, J., Winters, A., Tuluc, F., Benton, T. D., & Douglas, S. D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ab0416-188rr · Cited by 45
Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND
Sánchez, A. B., & Kaul, M. (2017) · Brain Sciences · doi:10.3390/brainsci7030025 · Cited by 45
Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model
Omeragic, A., Kara-Yacoubian, N., Kelschenbach, J., Sahin, C., Cummins, C. L., Volsky, D. J., & Bendayan, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-45878-6 · Cited by 46
Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches
Schnoll, J. G., Temsamrit, B., Zhang, D., Song, H., Ming, G., & Christian, K. M. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09880-z · Cited by 45
Post-traumatic stress is associated with verbal learning, memory, and psychomotor speed in HIV-infected and HIV-uninfected women
Rubin, L. H., Pyra, M. N., Cook, J. Α., Weber, K. M., Cohen, M. H., Martin, E. M., Valcour, V., Milam, J. E., Anastos, K., Young, M., et al. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0380-9 · Cited by 46
HIV ‐associated neurocognitive disorder in HIV ‐infected K oreans: the K orean N euro AIDS P roject
Ku, N. S., Lee, Y., Ahn, J. Y., Song, J., Kim, M., Kim, S. M., Jeong, S. J., Hong, K., Kim, E., Han, S. H., et al. (2014) · HIV Medicine · doi:10.1111/hiv.12137 · Cited by 44
Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders
Heaps, J. M., Valcour, V., Chalermchai, T., Paul, R. H., Rattanamanee, S., Siangphoe, U., Sithinamsuwan, P., Chairangsaris, P., Nidhinandana, S., Tipsuk, S., et al. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2012.733682 · Cited by 44
Increased neurocognitive intra-individual variability is associated with declines in medication adherence in HIV-infected adults.
Thaler, N. S., Sayegh, P., Arentoft, A., Thames, A. D., Castellon, S. A., & Hinkin, C. H. (2015) · Neuropsychology · doi:10.1037/neu0000191 · Cited by 44
Multidimensional effects of acculturation on English-language neuropsychological test performance among HIV+ Caribbean Latinas/os
Arentoft, A., Byrd, D., Robbins, R. N., Monzones, J., Miranda, C., Rosario, A. K., Coulehan, K., Fuentes, A., Germano, K. K., D’Aquila, E., et al. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2012.683856 · Cited by 44
Self-citation
Neurocognitive decline in HIV patients is associated with ongoing T‐cell activation in the cerebrospinal fluid
Grauer, O. M., Reichelt, D., Oelker-Grueneberg, U., Lohmann, H., Schneider‐Hohendorf, T., Schulte‐Mecklenbeck, A., Groß, C. C., Meuth, S. G., Wiendl, H., & Husstedt, I. W. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.227 · Cited by 46
Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study
for HIV-Associated Neurocognitive Disorders in Japanese (J-HAND study group), Kinai, E., Komatsu, K., Sakamoto, M., Taniguchi, T., Nakao, A., Igari, H., Takada, K., Watanabe, A., Takahashi-Nakazato, A., et al. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0580-6 · Cited by 44
Self-citation
HIV Alters Gap Junction-Mediated Intercellular Communication in Human Brain Pericytes
Cho, H. J., Kuo, A. M.-S., Bertrand, L., & Toborek, M. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00410 · Cited by 46
Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV
Zamudio‐Rodríguez, A., Belaunzarán-Zamudio, P. F., Sierra-Madero, J. G., Cuellar‐Rodríguez, J., Crabtree‐Ramírez, B., Alcalá-Zermeño, J. L., Amieva, H., & Ávila‐Funes, J. A. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0100 · Cited by 47
Relationships between cognition, function, and quality of life among HIV+ Canadian men
and investigators from the Positive Brain Health Now Study, Mayo, N. E., Brouillette, M., Scott, S. C., Harris, M., Smaill, F., Smith, G. H. R., Thomas, R., & Fellows, L. K. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02291-w · Cited by 44
Antiretroviral drug concentrations in brain tissue of adult decedents
Ferrara, S. M., Bumpus, N. N., Ma, Q., Ellis, R. J., Soontornniyomkij, V., Fields, J. A., Bharti, A., Achim, C. L., Moore, D. J., & Letendre, S. L. (2020) · AIDS · doi:10.1097/qad.0000000000002628 · Cited by 44
Self-citation
Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy
Cruse, B., Cysique, L. A., Markus, R., & Brew, B. J. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0092-3 · Cited by 46
Select Neurocognitive Impairment in HIV-Infected Women: Associations with HIV Viral Load, Hepatitis C Virus, and Depression, but Not Leukocyte Telomere Length
Giesbrecht, C. J., Thornton, A. E., Hall-Patch, C., Maan, E. J., Côté, H. C. F., Money, D., Murray, M. C. M., & Pick, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089556 · Cited by 47
Risk and Protective Factors for Retention in HIV Care
Waldrop‐Valverde, D., Guo, Y., Ownby, R. L., Rodriguez, A. E., & Jones, D. L. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0633-7 · Cited by 43
Neurocognitive Functioning in Antiretroviral Therapy–Naïve Youth With Behaviorally Acquired Human Immunodeficiency Virus
Nichols, S., Bethel, J., Garvie, P. A., Patton, D. E., Thornton, S., Kapogiannis, B. G., Ren, W., Major‐Wilson, H., Puga, A. M., & Woods, S. P. (2013) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2013.07.006 · Cited by 43
Self-citation
Effects of HIV and Early Life Stress on Amygdala Morphometry and Neurocognitive Function
Clark, U. S., Cohen, R. A., Sweet, L. H., Gongvatana, A., Devlin, K. N., Hana, G., Westbrook, M. L., Mulligan, R. C., Jerskey, B. A., White, T. L., et al. (2012) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712000434 · Cited by 46
Peripheral Neuropathy in Primary HIV Infection Associates With Systemic and Central Nervous System Immune Activation
Wang, S. X. Y., Ho, E. L., Grill, M. F., Lee, E., Peterson, J. J., Robertson, K., Fuchs, D., Sinclair, E., Price, R. W., & Spudich, S. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000167 · Cited by 43
(1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy
Hoenigl, M., Oliveira, M. F., Pérez‐Santiago, J., Zhang, Y., Morris, S., McCutchan, A., Finkelman, M., Marcotte, T. D., Ellis, R. J., & Gianella, S. (2016) · Medicine · doi:10.1097/md.0000000000003162 · Cited by 43
Self-citation
Plasma microRNA profiling predicts HIV-associated neurocognitive disorder
Asahchop, E. L., Akinwumi, S. M., Branton, W. G., Fujiwara, E., Gill, M. J., & Power, C. (2016) · AIDS · doi:10.1097/qad.0000000000001160 · Cited by 43
Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
Ambrosius, B., Faissner, S., Guse, K., von Lehe, M., Grunwald, T., Gold, R., Grewe, B., & Chan, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0829-2 · Cited by 43
IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury
Thaney, V. E., O’Neill, A. M., Hoefer, M. M., Maung, R., Sánchez, A. B., & Kaul, M. (2017) · Scientific Reports · doi:10.1038/srep46514 · Cited by 43
Neuropathogenesis of human immunodeficiency virus infection
Sillman, B., Woldstad, C., McMillan, J., & Gendelman, H. E. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63849-6.00003-7 · Cited by 44
HIV in the cART era and the mitochondrial: immune interface in the CNS
Fields, J. A., & Ellis, R. J. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.04.003 · Cited by 43
Self-citation
Geriatric Syndromes in Older Adults Living with HIV and Cognitive Impairment
Hosaka, K. R. J., Greene, M. L., Premeaux, T. A., Javandel, S., Allen, I. E., Ndhlovu, L. C., & Valcour, V. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16034 · Cited by 45
Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice
Fields, J. A., Swinton, M. K., Carson, A., Soontornniyomkij, B., Lindsay, C., Han, M. M., Frizzi, K. E., Sambhwani, S., Murphy, A. N., Achim, C. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53466-x · Cited by 44
Self-citation
Cumulative Burden of Depression and Neurocognitive Decline Among Persons With HIV: A Longitudinal Study
Paolillo, E. W., Pasipanodya, E. C., Moore, R. C., Pence, B. W., Atkinson, J. H., Grelotti, D. J., Grant, I., Heaton, R. K., & Moore, D. J. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002346 · Cited by 43
Self-citation
Co-receptor signaling in the pathogenesis of neuroHIV
Nickoloff-Bybel, E. A., Festa, L. K., Meucci, O., & Gaskill, P. J. (2021) · Retrovirology · doi:10.1186/s12977-021-00569-x · Cited by 46
CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
Bhargavan, B., Woollard, S. M., Mcmillan, J. E. M., & Kanmogne, G. D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00500-0 · Cited by 45
Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART
Drewes, J. L., Meulendyke, K. A., Liao, Z., Witwer, K. W., Gama, L., Ubaida‐Mohien, C., Li, M., Notarangelo, F. M., Tarwater, P. M., Schwarcz, R. M., et al. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0334-2 · Cited by 43
The Role of Employment on Neurocognitive Reserve in Adults With HIV: A Review of the Literature
Vance, D. E., Cody, S. L., Yoo‐Jeong, M., Jones, G. “. D., & Nicholson, W. C. (2015) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2015.04.003 · Cited by 43
HIV-1 Transgenic Rat Prefrontal Cortex Hyper-Excitability is Enhanced by Cocaine Self-Administration
Wayman, W. N., Chen, L., Hu, X., & Napier, T. C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.366 · Cited by 42
A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders
Tierney, S. M., Sheppard, D. P., Kordovski, V. M., Faytell, M. P., Avci, G., & Woods, S. P. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-016-0510-z · Cited by 42
Self-citation
Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
Huang, Z., Tomitaka, A., Raymond, A., & Nair, M. (2017) · Gene Therapy · doi:10.1038/gt.2017.35 · Cited by 43
Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders
McLaurin, K. A., Booze, R. M., & Mactutus, C. F. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0544-x · Cited by 42
An SIV/macaque model targeted to study HIV-associated neurocognitive disorders
Beck, S. E., Queen, S. E., Pate, K. A. M., Mangus, L. M., Abreu, C. M., Gama, L., Witwer, K. W., Adams, R. J., Zink, M. C., Clements, J. E., et al. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0582-4 · Cited by 42
Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors
Nookala, A. R., Schwartz, D. C., Chaudhari, N. S., Glazyrin, A., Stephens, E. B., Berman, N. E. J., & Kumar, A. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.04.018 · Cited by 42
Efficient Expression of HIV in Immunocompetent Mouse Brain Reveals a Novel Nonneurotoxic Viral Function in Hippocampal Synaptodendritic Injury and Memory Impairment
Kelschenbach, J., He, H., Kim, B., Borjabad, A., Gu, C., Chao, W., Do, M., Sharer, L. R., Zhang, H., Arancio, O., et al. (2019) · mBio · doi:10.1128/mbio.00591-19 · Cited by 43
The Intersection of Cognitive Ability and HIV: A Review of the State of the Nursing Science
Waldrop, D. G., Irwin, C., Nicholson, W. C., Lee, C. A., Webel, A. R., Fazeli, P. L., & Vance, D. E. (2021) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000232 · Cited by 45
Enhanced Human Immunodeficiency Virus Type 1 Expression and Neuropathogenesis in Knockout Mice Lacking Type I Interferon Responses
He, H., Sharer, L. R., Chao, W., Gu, C., Borjabad, A., Hadas, E., Kelschenbach, J., Ichiyama, K., Do, M., Potash, M. J., et al. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000026 · Cited by 42
Neurologic complications of HIV infection.
Spudich, S., & Ances, B. M. (2012) · Europe PMC (PubMed Central) · Cited by 41
The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV
Hammond, E. R., Crum, R. M., Treisman, G. J., Mehta, S. H., Marra, C. M., Clifford, D. B., Morgello, S., Simpson, D. M., Gelman, B. B., Ellis, R. J., et al. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu098 · Cited by 41
Self-citation
Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
Suh, J., Sinclair, E., Peterson, J. J., Lee, E., Kyriakides, T. C., Li, F., Hagberg, L., Fuchs, D., Price, R. W., Gisslén, M., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0199-y · Cited by 41
Cognitive Functioning in Adults Aging with HIV: A Cross-Sectional Analysis of Cognitive Subtypes and Influential Factors
Fazeli, P. L., Crowe, M. G., Ross, L. A., Wadley, V. G., Ball, K., & Vance, D. E. (2014) · Journal of Clinical Research in HIV AIDS and Prevention · doi:10.14302/issn.2324-7339.jcrhap-13-191 · Cited by 41
Health-Related Everyday Functioning in the Internet Age: HIV-Associated Neurocognitive Disorders Disrupt Online Pharmacy and Health Chart Navigation Skills
Woods, S. P., Iudicello, J. E., Morgan, E. E., Cameron, M. V., Doyle, K. L., Smith, T. V., & Cushman, C. (2016) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acv090 · Cited by 41
Self-citation
Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals
Underwood, J., & Winston, A. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0324-x · Cited by 41
Neuroinflammation and Behavior in HIV-1 Transgenic Rats Exposed to Chronic Adolescent Stress
Rowson, S. A., Harrell, C. S., Bekhbat, M., Gangavelli, A., Wu, M. J., Kelly, S. D., Reddy, R., & Neigh, G. N. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00102 · Cited by 43
Alarmins and central nervous system inflammation in HIV ‐associated neurological disorders
Gougeon, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12570 · Cited by 41
Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV
Wallace, L. M. K., Ferrara, M., Brothers, T. D., Garlassi, S., Kirkland, S., Theou, O., Zona, S., Mussini, C., Moore, D. J., Rockwood, K. J., et al. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0189 · Cited by 41
Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients
For the Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group, Haddow, L. J., Laverick, R., Daskalopoulou, M., McDonnell, J., Lampe, F. C., Gilson, R. J. C., Speakman, A., Antinori, A., Balestra, P., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1683-z · Cited by 41
Self-citation
Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States
Marquine, M. J., Heaton, A., Johnson, N. X., Mindt, M. R., Cherner, M., Bloss, C. S., Hulgan, T., Umlauf, A., Moore, D. J., Fazeli, P. L., et al. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000832 · Cited by 41
Self-citation
Exercise and cognitive function in people living with HIV: a scoping review
Quigley, A., O’Brien, K. K., Parker, R. M. N., & MacKay-Lyons, M. J. (2018) · Disability and Rehabilitation · doi:10.1080/09638288.2018.1432079 · Cited by 41
Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy
Letendre, S. L., Bharti, A., Valero, I., Hanson, B. A., Franklin, D. R., Woods, S. P., Gianella, S., Oliveira, M. F., Heaton, R. K., Grant, I., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy170 · Cited by 42
Self-citation
Cognitive Performance and Frailty in Older HIV-Positive Adults
Paul, R. H., Cooley, S., Garcia-Egan, P. M., & Ances, B. M. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001790 · Cited by 42
Peripheral immune dysregulation in the ART era of HIV-associated neurocognitive impairments: A systematic review
Williams, M. E., Ipser, J., Stein, D. J., Joska, J. A., & Naudé, P. J. W. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104689 · Cited by 43
HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System
Nickoloff-Bybel, E. A., Calderon, T. M., Gaskill, P. J., & Berman, J. W. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09927-6 · Cited by 42
The Expanding Regulatory Mechanisms and Cellular Functions of Long Non-coding RNAs (lncRNAs) in Neuroinflammation
Tripathi, S., Shree, B., Mohapatra, S., Swati, S., Basu, A., & Sharma, V. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02268-8 · Cited by 43
Combined effects of aging and HIV infection on semantic verbal fluency: A view of the cortical hypothesis through the lens of clustering and switching
Iudicello, J. E., Woods, S. P., Deutsch, R., Grant, I., & Ce, T. H. N. R. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2011.651103 · Cited by 41
Self-citation
Executive Functioning in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure
Nichols, S., Chernoff, M. C., Malee, K., Sirois, P. A., Woods, S. P., Williams, P. L., Yildirim, C., Delis, D. C., & Kammerer, B. L. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piw049 · Cited by 41
Self-citation
Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV
Mastrorosa, I., Pinnetti, C., Brita, A. C., Mondi, A., Lorenzini, P., Duca, G. D., Vergori, A., Mazzotta, V., Gagliardini, R., Camici, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac658 · Cited by 40
HIV integration in the human brain is linked to microglial activation and 3D genome remodeling
Plaza-Jennings, A. L., Valada, A., O’Shea, C. P., Iskhakova, M., Hu, B., Javidfar, B., Hutta, G. B., Lambert, T. Y., Murray, J., Kassim, B. S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.016 · Cited by 42
Self-citation
Neurocognitive Impairment is Associated with Lower Health Literacy Among Persons Living with HIV Infection
Morgan, E. E., Iudicello, J. E., Cattie, J. E., Blackstone, K., Grant, I., & Woods, S. P. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0851-7 · Cited by 41
Self-citation
The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals
Patel, S. M., Thames, A. D., Arbid, N., Panos, S. E., Castellon, S. A., & Hinkin, C. H. (2013) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2013.783000 · Cited by 40
Assessing and Treating Forgetfulness and Cognitive Problems in Adults With HIV
Vance, D. E., Fazeli, P. L., Moneyham, L. L., Keltner, N. L., & Raper, J. L. (2013) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2012.03.006 · Cited by 40
Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers
Tebas, P., Spitsin, S. V., Barrett, J. S., Tuluc, F., Elci, O. U., Korelitz, J., Wagner, W., Winters, A., Kim, D., Catalano, R., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000638 · Cited by 40
HIV clades B and C are associated with reduced brain volumetrics
Ortega, M., Heaps, J. M., Joska, J. A., Vaida, F., Seedat, S., Stein, D. J., Paul, R. H., & Ances, B. M. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0202-x · Cited by 40
Self-citation
Cytomegalovirus, aging, and HIV: a perfect storm.
Barrett, L., Fowke, K. R., & Grant (2012) · PubMed · Cited by 40
Effects of social adversity and HIV on subcortical shape and neurocognitive function
Thames, A. D., Kuhn, T. P., Mahmood, Z., Bilder, R. M., Williamson, T. J., Singer, E. J., & Arentoft, A. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9676-0 · Cited by 40
A systematic review of prospective memory in HIV disease: from the laboratory to daily life
Avci, G., Sheppard, D. P., Tierney, S. M., Kordovski, V. M., Sullivan, K. L., & Woods, S. P. (2017) · The Clinical Neuropsychologist · doi:10.1080/13854046.2017.1373860 · Cited by 40
Self-citation
Effects of comorbidity burden and age on brain integrity in HIV
Saloner, R., Heaton, R. K., Campbell, L. M., Chen, A. M., Franklin, D. R., Ellis, R. J., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002192 · Cited by 40
Self-citation
Role of T Lymphocytes in HIV Neuropathogenesis
Subra, C., & Trautmann, L. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00445-6 · Cited by 40
Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia
Swinton, M. K., Carson, A., Telese, F., Sánchez, A. B., Soontornniyomkij, B., Rad, L., Batki, I. B., Quintanilla, B., Pérez‐Santiago, J., Achim, C. L., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104502 · Cited by 40
Self-citation
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Nedelcovych, M. T., Kim, B.-H., Zhu, X., Lovell, L. E., Manning, A. A., Kelschenbach, J., Hadas, E., Chao, W., Prchalová, E., Dash, R. P., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09859-w · Cited by 41
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
Santos, G., Locatelli, I., Métral, M., Calmy, A., Lecompte, T., Nadin, I., Hauser, C. V., Cusini, A., Hasse, B. K., Kovari, H., et al. (2019) · Europe PMC (PubMed Central) · doi:10.1093/ofid/ofz277 · Cited by 40
Neuronal‐derived extracellular vesicles are enriched in the brain and serum of HIV‐1 transgenic rats
Dagur, R. S., Liao, K., Sil, S., Niu, F., Sun, Z., Lyubchenko, Y. L., Peeples, E. S., Hu, G., & Buch, S. J. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1703249 · Cited by 40
Two‐pore channels regulate Tat endolysosome escape and Tat‐mediated HIV‐1 LTR transactivation
Khan, N., Halcrow, P. W., Lakpa, K. L., Afghah, Z., Miller, N., Dowdy, S. F., Geiger, J. D., & Chen, X. (2020) · The FASEB Journal · doi:10.1096/fj.201902534r · Cited by 40
Prefrontal gating of sensory input differentiates cognitively impaired and unimpaired aging adults with HIV
Spooner, R. K., Wiesman, A. I., O’Neill, J., Schantell, M. D., Fox, H. S., Swindells, S., & Wilson, T. W. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa080 · Cited by 40
Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016
Lam, J. O., Lee, C., Gilsanz, P., Hou, C. E., Leyden, W. A., Satre, D. D., Flamm, J., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2021) · AIDS · doi:10.1097/qad.0000000000003134 · Cited by 40
Functions of the Chemokine Receptor CXCR4 in the Central Nervous System and Its Regulation by μ-Opioid Receptors
Nash, B., & Meucci, O. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00005-1 · Cited by 40
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)
Kolson, D. L. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00612-2 · Cited by 42
Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy
Gabuzda, D. H., Yin, J., Misra, V., Chettimada, S., & Gelman, B. B. (2023) · Viruses · doi:10.3390/v15041009 · Cited by 39
Self-citation

Authors: Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T. L., Wong, J., Grant, I., & For the CHARTER Group
Affiliations: University of California San Diego (US)
From the University of California (R.K.H., D.R.F., S.P.W., C.A., F.V., R.J.E., S.L.L., T.D.M., J.H.A., O.R.V., M.J.T., J.A.M., I.A., A.G., C.F.-N., T.L.J., I.G.), San Diego; University of California (J.W.), San Francisco; Washington University (D.B.C.), St. Louis, MO; Mount Sinai School of Medicine (M.R.-M., S.M., D.M.S.), New York, NY; University of Washington (A.C.C., C.M.M.), Seattle; University of Texas Medical Branch (B.B.G.), Galveston; and Johns Hopkins University (J.C.M.), Baltimore, MD.
ORCID: Heaton, R.K.
Clifford, D.B.
Franklin, D.R.
Woods, S.P.
Vaida, F.
Ellis, R.J.
Letendre, S.L.
Marcotte, T.D.
Taylor, M.J.
Collier, A.C.
Marra, C.M.
McArthur, J.C.
Morgello, S.
Simpson, D.M.
McCutchan, J.A.
Jernigan, T.L.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-12-07
Volume: 75
Issue: 23
Pages: 2087-2096
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0b013e318200d727
PMC: PMC2995535
OpenAlex: W2137321682
Cited by: 2,353
References: 33
Citations by year: 2026: 92 · 2025: 93 · 2024: 119 · 2023: 131 · 2022: 127 · 2021: 182 · 2020: 172 · 2019: 225 · 2018: 153 · 2017: 202 · 2016: 181 · 2015: 172 · 2014: 165 · 2013: 152 · 2012: 115
FWCI: 38.09
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Neurology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Fordham Research Commons (Fordham University) (submittedVersion)
Funders: National Institutes of Health (5u01ai069495-05, n01mh22005-16-0-1, 5r01ag024506-03, 5r01ns036524-10, N01 MH22005, MH22005)
Centers for Disease Control and Prevention (U2G PS00623)
U.S. Public Health Service (R213857-53187, NIMH-22005)
National Institute on Alcohol Abuse and Alcoholism (R01 AA13419, R01AA013419, R32AA17321)
National Institute on Aging (R01AG015301, U01‐AG10483, R01AG031224, R01-AG024506, R01 AG-15301, U01AG010483, R01AG022381, U19AG010483)
National Heart, Lung, and Blood Institute (R01HL084229, R01 HL95089, R01 HL84229, R01HL095089)
National Institute of Mental Health (U01MH083507, U01-MH83506, R21-MH85610, R01MH067831, U01MH083506, R01-MH73419, N01 MH-22005, R01 MH73433, R01MH079881, N01 MH22005-08, R01 MH-60720, R01 MH78748, R01MH058076, R21MH78728, MH 22005, N01MH022005, R01MH064907, K23MH079718, R01MH081861, MH058076, R01MH085608, R01 MH78737, R01MH64907, R01MH083552, R01MH073419, R24-MH-59724, U13 MH81676, R32 MH77487, R01MH079886, R24MH059724, R21MH078728, U01MH083501, R01MH38552, R01MH078737, R21MH085610, R01 MH81861, R01 MH83552, R01 MH79752, R01MH078748, R01MH073433, R01MH079752, R01MH060720, P30MH62512, R01MH061146, MH085608-01, MH083506-02, R01 MH61146, R01 MH79881, R01 MH075673, R21MH083573, R01MH084796, MH083552-02, P30MH062512, U13MH081676, R01 MH58076)
National Institute on Drug Abuse (P50DA026306, R01 DA21115, RC2DA029475, DA026306-01, P01DA012065, P50DA26306, RC2-DA29475, P01-DA12065, DA012065-10, DA026146, P01DA026146, R03DA022137, R01DA021115)
National Institute of Allergy and Infectious Diseases (AI 27757, R01-AI47033, AI-069434, AI069918, UO1AI69495, U01 AI74521, U01AI074521, R01AI034235, U01AI069432, R01AI047033, 00-AI-0005, U01 AI69432, R01AI087145, P01AI057005, AI069438, AI068543, 1R01 NS/AI34235, P30AI027757, U01AI069918)
National Institute of Neurological Disorders and Stroke (R01 NS44807, R21NS069355, R01NS049465, UO1 NS32228, R01NS044807, R01NS49465, RC1NS068904, R01-NS-41198, R01NS041198, R01-NS36524, R01NS051132, U01NS032228)
National Center for Research Resources (U24RR021992, U24RR021382, K30RR22681, K30RR022681, U24 RR21382, U24RR019701)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: HIV-associated neurocognitive disorders, HIV-associated dementia, highly active antiretroviral therapy, CD4 nadir, viral suppression, comorbidities, asymptomatic neurocognitive impairment, mild neurocognitive disorder, HIV infection
MeSH terms: Activities of Daily Living, Adult, Algorithms, Cognition Disorders, Disability Evaluation, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Neurologic Examination, Neuropsychological Tests, Psychiatric Status Rating Scales, Retrospective Studies, Models, Statistical, HIV Infections, Cross-Over Studies, Observation, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks